Findings of RAS- and BRAF-like molecular signatures in PTC subtypes defined by transcriptome profiling (62), which also distinguish follicular variants of PTC with different tendencies of regional nodal disease (6), suggest that mutation identity (RAS vs. BRAF) is more important for tumor invasiveness and spreading rather than determining the histologic tumor growth pattern. The gene discussed is BRAF; the disease is neoplasm.